HOME Top Market Reports Apheresis Market by Product (Plasma & Component Separator, Hemoperfusion, Disposable), Procedure (Therapeutic, Photopheresis, Donor), Application (Plasmapheresis, Plateletpheresis), Technology (Centrifuge, Membrane Separation) - Global Forecast to 2021

Apheresis Market by Product (Plasma & Component Separator, Hemoperfusion, Disposable), Procedure (Therapeutic, Photopheresis, Donor), Application (Plasmapheresis, Plateletpheresis), Technology (Centrifuge, Membrane Separation) - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: February 2017
Report Code: MD 1407

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global apheresis market was valued at USD 1.42 Billion in 2016. This market is expected to grow at a CAGR of 7.7% during the forecast period (2016–2021) to reach USD 2.06 Billion by 2021. The base year considered for the study is 2015 and the forecast for the market size is provided for the period between 2016 and 2021. Some of the key factors driving the growth of the market include rising prevalence of diseases and growing number of trauma and injury cases, increasing demand for source plasma from biopharmaceutical companies, and the presence of a favorable reimbursement scenario for apheresis. Untapped emerging regions showcase new growth opportunities for this market. However, the growth of the market is restrained by the lack of awareness about apheresis and the high cost of these procedures.

This report aims to estimate the market size and future growth potential of the apheresis market across different segments such as product type, procedure, technology, application, and region. Based on procedure, the market is segmented into automated/donor apheresis and therapeutic apheresis. The automated/donor apheresis segment accounted for the largest share of the market in 2015, owing to the increasing demand for safer blood components for transfusion and rising need to improve blood center efficiency.

Geographically, North America dominated the market in 2015. The large share of this region can be attributed to the presence of developed healthcare systems in the U.S. & Canada, increasing applications of apheresis products in plasma collection and fractionation, the presence of established distribution channels, and growing focus on apheresis blood collection to overcome blood shortage.

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global apheresis market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market revenues were determined through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the product markets were determined using secondary sources and verified through primary sources. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data is consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Apheresis Market

To know about the assumptions considered for the study, download the pdf brochure

The key players in this market are Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan).

Target Audience

  • Apheresis product manufacturers
  • Blood transfusion product manufacturers
  • Blood banks & blood collection centers
  • Hospitals & attached blood banks
  • Therapeutic apheresis service providers
  • Biopharmaceutical companies (plasma fractionation players)
  • Market research and consulting firms
  • Health insurance payers

Scope of the Report

This research report categorizes the global apheresis market into the following segments:

Global Apheresis Market, by Product

  • Apheresis Devices
    • Plasma Separators
    • Plasma Component Separators
    • Immunoadsorption Columns
    • Plasma Perfusion Columns
    • Hemoperfusion Columns
  • Apheresis Disposables

Global Apheresis Market, by Procedure

  • Automated/Apheresis Blood Collection (Donor Apheresis)
  • Therapeutic Apheresis
    • Therapeutic Apheresis Market, by Disease
      • Neurological Disorders
      • Blood Disorders
      • Cardiovascular Disorders
      • Renal Disorders
      • Autoimmune Disorders
      • Metabolic Disorders
      • Other Disorders
    • Therapeutic Apheresis Market, By Procedure
      • Therapeutic Plasma Exchange (TPE)
      • Therapeutic Cytapheresis
        • Therapeutic Erythrocytapheresis
        • Therapeutic Plateletpheresis
        • Leukapheresis
      • Photopheresis
      • Extracorporeal Immunoadsorption (ECI)

Global Apheresis Market, by Technology

  • Centrifugation
    • Intermittent Flow
    • Continuous Flow
  • Membrane Separation

Global Apheresis Market, by Application

  • Plasmapheresis
  • Plateletpheresis
  • Erythrocytapheresis
  • Leukapheresis
  • Other Applications

Global Apheresis Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLA)
  • The Middle East and Africa

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Geographic Analysis

  • Further breakdown of the Rest of Asia-Pacific apheresis market in South Korea, Australia, New Zealand, and other countries

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 18)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 22)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
           2.4.1 Assumptions for the Study

3 Executive Summary (Page No. - 29)

4 Premium Insights (Page No. - 36)
    4.1 Apheresis: Market Overview
    4.2 Asia-Pacific: Apheresis Market, By Application
    4.3 Geographic Snapshot of the Apheresis Market
    4.4 Geographic Mix: Apheresis Market
    4.5 Apheresis Market: Developing vs Developed Markets

5 Market Overview (Page No. - 40)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Rising Prevalence of Diseases and Growing Number of Trauma and Injury Cases
                    5.2.1.2 Increasing Demand for Source Plasma From Biopharmaceutical Companies
                    5.2.1.3 Rising Demand for Blood Components and Growing Concerns Regarding Blood Safety
                    5.2.1.4 Increase in the Number of Complex Surgical Procedures
                    5.2.1.5 Favorable Reimbursement Policies for Apheresis Procedures
           5.2.2 Market Restraints
                    5.2.2.1 Lack of Awareness About Apheresis Procedures
                    5.2.2.2 High Cost of Apheresis Devices and Procedures
                    5.2.2.3 Scarcity of Qualified Donors
           5.2.3 Market Opportunities
                    5.2.3.1 Extending the Reach of Apheresis in the Untapped Pediatric Segment
                    5.2.3.2 Emerging Economies With Increasing Investments From Government Bodies and Leading Players
           5.2.4 Market Challenges
                    5.2.4.1 Recruitment of Voluntary Non-Remunerated Donors
                    5.2.4.2 Blood Transfusion Safety in Developing Countries

6 Industry Insights (Page No. - 51)
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 New Indications for Plasma Products
           6.2.2 Growing Number of Agreements and Partnerships
    6.3 Porter’s Five Force Analysis
           6.3.1 Threat of New Entrants
           6.3.2 Threat of Substitutes
           6.3.3 Bargaining Power of Suppliers
           6.3.4 Bargaining Power of Buyers
           6.3.5 Intensity of Competitive Rivalry
    6.4 Vendor Benchmarking
           6.4.1 Product Portfolio Analysis: Apheresis Market
    6.5 Regulatory Analysis
           6.5.1 North America
                    6.5.1.1 U.S.
                    6.5.1.2 Canada
           6.5.2 Europe
           6.5.3 Asia-Pacific
                    6.5.3.1 Japan
                    6.5.3.2 China
                    6.5.3.3 India

7 Global Apheresis Market, By Procedure (Page No. - 61)
    7.1 Introduction
    7.2 Automated/Apheresis Blood Collection (Donor Apheresis)
    7.3 Therapeutic Apheresis
           7.3.1 Therapeutic Apheresis Market, By Disease
                    7.3.1.1 Neurological Disorders
                    7.3.1.2 Blood Disorders
                    7.3.1.3 Cardiovascular Disorders
                    7.3.1.4 Renal Disorders
                    7.3.1.5 Autoimmune Disorders
                    7.3.1.6 Metabolic Disorders
                    7.3.1.7 Other Disorders
           7.3.2 Therapeutic Apheresis Market, By Procedure
                    7.3.2.1 Therapeutic Plasma Exchange (TPE)
                    7.3.2.2 Therapeutic Cytapheresis
                               7.3.2.2.1 Therapeutic Erythrocytapheresis
                               7.3.2.2.2 Therapeutic Plateletphersis
                               7.3.2.2.3 Leukapheresis
                    7.3.2.3 Photopheresis
                    7.3.2.4 Extracorporeal Immunoadsorption (ECI)

8 Global Apheresis Market, By Product (Page No. - 85)
    8.1 Introduction
    8.2 Apheresis Devices
           8.2.1 Plasma Separators
           8.2.2 Plasma Component Separators
           8.2.3 Immunoadsorption Columns
           8.2.4 Plasma Perfusion Columns
           8.2.5 Hemoperfusion Columns
    8.3 Apheresis Disposables

9 Global Apheresis Market, By Technology (Page No. - 97)
    9.1 Introduction
    9.2 Centrifugation
           9.2.1 Intermittent Flow
           9.2.2 Continuous Flow
    9.3 Membrane Separation

10 Global Apheresis Market, By Application (Page No. - 105)
     10.1 Introduction
     10.2 Plasmapheresis
     10.3 Plateletpheresis
     10.4 Erythrocytapheresis
     10.5 Leukapheresis
     10.6 Other Applications

11 Apheresis Market, By Region (Page No. - 113)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 France
             11.3.3 U.K.
             11.3.4 Italy
             11.3.5 Spain
             11.3.6 Rest of Europe (RoE)
     11.4 Asia-Pacific (APAC)
             11.4.1 Japan
             11.4.2 China
             11.4.3 India
             11.4.4 Rest of Asia-Pacific (RoAPAC)
     11.5 Latin America
             11.5.1 Brazil
             11.5.2 Mexico
             11.5.3 Rest of Latin America (RoLA)
     11.6 Middle East and Africa

12 Competitive Landscape (Page No. - 164)
     12.1 Overview
     12.2 Market Share Analysis
     12.3 Competitive Situation and Trends
     12.4 Agreements, Partnerships, and Collaborations
     12.5 Mergers and Acquisitions
     12.6 Expansions
     12.7 Product Launches
     12.8 Other Strategies

13 Company Profiles (Page No. - 170)
(Overview, Products & Services, Strategies & Insights, Developments and MnM View)*
     13.1 Introduction
     13.2 Cerus Corporation
     13.3 Fresenius SE & Co. KGaA
     13.4 Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
     13.5 Haemonetics Corporation
     13.6 Terumo BCT, Inc.
     13.7 Hemacare Corporation
     13.8 B. Braun Melsungen AG
     13.9 Kaneka Corporation
     13.10 Kawasumi Laboratories Inc.
     13.11 Nikkiso Co., Ltd.

*Details on Overview, Products & Services, Strategies & Insights, Developments and MnM View Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 196)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Other Developments
     14.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.5 Introducing RT: Real-Time Market Intelligence
     14.6 Available Customizations
     14.7 Related Reports
     14.8 Author Details


List of Tables (174 Tables)

Table 1 Global Apheresis Market Snapshot
Table 2 Increasing Demand for Source Plasma From Biopharmaceutical Companies to Drive Market Growth
Table 3 Required Units of Blood and Blood Components, By Type of Surgery
Table 4 U.S.: Payment Rates for Apheresis Procedures for the Year 2016 & 2017
Table 5 Lack of Awareness & Challenges in Donor Recruitment to Restrict Market Growth
Table 6 Frequency of Blood Donations From Healthy Donors
Table 7 Extending the Reach of Apheresis in the Untapped Pediatric Segment Offers Significant Growth Opportunities
Table 8 Recruitment of Voluntary Non-Remunerated Donors is A Major Challenge in the Market
Table 9 Global Apheresis Market Size, By Procedure, 2014–2021 (USD Million)
Table 10 Global Market Size for Automated Blood Collection, By Country, 2014–2021 (USD Million)
Table 11 Global Therapeutic Apheresis Market Size, By Country, 2014–2021, (USD Million)
Table 12 Global Estimated Disability-Adjusted Life Years (Dalys), By Disease, 2015-2030 (Population in 000’)
Table 13 Global Therapeutic Apheresis Market Size, By Disease, 2014–2021, (USD Million)
Table 14 Neurological Disorders: Estimated Dalys By Region, 2015-2030 (000’)
Table 15 Neurological Diseases/Disorders Treated By Therapeutic Apheresis
Table 16 Global Market Size for Neurological Disorders, By Country, 2014–2021, (USD Million)
Table 17 Global Apheresis Market Size for Blood Disorders, By Country, 2014–2021, (USD Million)
Table 18 Cardiovascular Disorders: Estimated Dalys, By Region, 2015–2030 (000’)
Table 19 Global Apheresis Market Size for Cardiovascular Disorders, By Country, 2014–2021, (USD Million)
Table 20 Global Apheresis Market Size for Renal Disorders, By Country, 2014–2021, (USD Million)
Table 21 Global Market Size for Autoimmune Disorders, By Country, 2014–2021, (USD Million)
Table 22 Digestive Disorders: Estimated Dalys By Region, 2015-2030 (000’)
Table 23 Global Apheresis Market Size for Metabolic Disorders, By Country, 2014–2021, (USD Million)
Table 24 Rheumatoid Arthritis: Estimated Dalys By Region, 2015-2030 (000’)
Table 25 Global Apheresis Market Size, for Other Disorders, By Country, 2014–2021, (USD Million)
Table 26 Global Therapeutic Apheresis Market Size, By Procedure, 2014–2021, (USD Million)
Table 27 Global Therapeutic Plasma Exchange Market Size, By Country, 2014–2021, (USD Million)
Table 28 Global Therapeutic Cytapheresis Market Size, By Country, 2014–2021, (USD Million)
Table 29 Global Therapeutic Cytapheresis Market Size, By Procedure, 2014–2021, (USD Million)
Table 30 Global Therapeutic Erythrocytapheresis Devices Market Size, By Country, 2014–2021, (USD Million)
Table 31 Global Therapeutic Plateletpheresis Market Size, By Country, 2014–2021, (USD Million)
Table 32 Leukemia: Estimated Dalys By Region, 2015-2030 (000’)
Table 33 Global Leukapheresis Market Size, By Country, 2014–2021 (USD Million)
Table 34 Global Photopheresis Market Size, By Country, 2014–2021, (USD Million)
Table 35 Global Extracorporeal Immunoadsorption Market Size, By Country, 2014–2021, (USD Million)
Table 36 Global Market, By Product, 2014–2021 (USD Million)
Table 37 Apheresis Devices/Systems in the Market
Table 38 Global Apheresis Devices Market Size, By Type, 2014–2021 (USD Million)
Table 39 Global Apheresis Devices Market Size, By Country, 2014–2021 (USD Million)
Table 40 Global Plasma Separators Market Size, By Country, 2014–2021 (USD Million)
Table 41 Global Plasma Component Separators Market Size, By Country, 2014–2021 (USD Million)
Table 42 Global Immunoadsorption Columns Market Size, By Country, 2014–2021 (USD Million)
Table 43 Global Plasma Perfusion Columns Market Size, By Country, 2014–2021 (USD Million)
Table 44 Global Hemoperfusion Columns Market Size, By Country, 2014–2021 (USD Million)
Table 45 Global Apheresis Disposables Market Size, By Country, 2014–2021 (USD Million)
Table 46 Global Apheresis Market Size, By Technology, 2014–2021 (USD Million)
Table 47 Centrifugation-Based Apheresis Devices
Table 48 Global Centrifugation Market Size, By Country, 2014–2021 (USD Million)
Table 49 Global Centrifugation Market Size, By Type, 2014–2021 (USD Million)
Table 50 Global Intermittent Flow Market Size, By Country, 2014–2021 (USD Million)
Table 51 Global Continuous Flow Market Size, By Country, 2014–2021 (USD Million)
Table 52 Size of Blood Components
Table 53 Membrane Separation-Based Apheresis Devices
Table 54 Global Membrane Separation Market Size, By Country, 2014–2021 (USD Million)
Table 55 Global Apheresis Market Size, By Application, 2014–2021 (USD Million)
Table 56 Total Source Plasma Collection in the U.S. & Europe, 2006–2015 (Thousand Liters)
Table 57 Global Market Size for Plasmapheresis, By Country, 2014–2021 (USD Million)
Table 58 Global Market Size for Plateletpheresis, By Country, 2014–2021 (USD Million)
Table 59 Global Apheresis Market Size for Erythrocytapheresis, By Country, 2014–2021 (USD Million)
Table 60 Global Market Size for Leukapheresis, By Country, 2014–2021 (USD Million)
Table 61 Global Apheresis Market Size for Other Applications, By Country, 2014–2021 (USD Million)
Table 62 Global Apheresis Market Size, By Region, 2014–2021 (USD Million)
Table 63 Global Market Size, By Country/Region, 2014–2021 (USD Million)
Table 64 North America: Total Hemophilia Patients, 2013 vs 2014 vs 2015
Table 65 North America: Apheresis Market Size, By Country, 2014–2021 (USD Million)
Table 66 North America: Market Size, By Procedure, 2014–2021 (USD Million)
Table 67 North America: Market Size, By Product, 2014–2021 (USD Million)
Table 68 North America: Market Size, By Device Type, 2014–2021 (USD Million)
Table 69 North America: Market Size, By Application, 2014–2021 (USD Million)
Table 70 North America: Market Size, By Technology, 2014–2021 (USD Million)
Table 71 U.S.: Apheresis Market Size, By Procedure, 2014–2021 (USD Million)
Table 72 U.S.: Market Size, By Product, 2014–2021 (USD Million)
Table 73 U.S.: Market Size, By Device Type, 2014–2021 (USD Million)
Table 74 U.S.: Market Size, By Application, 2014–2021 (USD Million)
Table 75 U.S.: Market Size, By Technology, 2014–2021 (USD Million)
Table 76 Canada: Apheresis Market Size, By Procedure, 2014–2021 (USD Million)
Table 77 Canada: Market Size, By Product, 2014–2021 (USD Million)
Table 78 Canada: Market Size, By Device Type, 2014–2021 (USD Million)
Table 79 Canada: Market Size, By Application, 2014–2021 (USD Million)
Table 80 Canada: Market Size, By Technology, 2014–2021 (USD Million)
Table 81 Europe: Apheresis Market Size, By Country/Region, 2014–2021 (USD Million)
Table 82 Europe: Apheresis Market Size, By Procedure, 2014–2021 (USD Million)
Table 83 Europe: Market Size, By Product, 2014–2021 (USD Million)
Table 84 Europe: Market Size, By Device Type, 2014–2021 (USD Million)
Table 85 Europe: Market Size, By Application, 2014–2021 (USD Million)
Table 86 Europe: Market Size, By Technology, 2014–2021 (USD Million)
Table 87 Germany: Apheresis Market Size, By Procedure, 2014–2021 (USD Million)
Table 88 Germany: Apheresis Market Size, By Product, 2014–2021 (USD Million)
Table 89 Germany: Apheresis Market Size, By Device Type, 2014–2021 (USD Million)
Table 90 Germany: Apheresis Market Size, By Application, 2014–2021 (USD Million)
Table 91 Germany: Market Size, By Technology, 2014–2021 (USD Million)
Table 92 France: Market Size, By Procedure, 2014–2021 (USD Million)
Table 93 France: Apheresis Market Size, By Product, 2014–2021 (USD Million)
Table 94 France: Apheresis Market Size, By Device Type, 2014–2021 (USD Million)
Table 95 France: Apheresis Market Size, By Application, 2014–2021 (USD Million)
Table 96 France: Apheresis Market Size, By Technology, 2014–2021 (USD Million)
Table 97 U.K.: Market Size, By Procedure, 2014–2021 (USD Million)
Table 98 U.K.: Apheresis Market Size, By Product, 2014–2021 (USD Million)
Table 99 U.K.: Apheresis Market Size, By Device Type, 2014–2021 (USD Million)
Table 100 U.K.: Market Size, By Application, 2014–2021 (USD Million)
Table 101 U.K.: Apheresis Market Size, By Technology, 2014–2021 (USD Million)
Table 102 Italy: Market Size, By Procedure, 2014–2021 (USD Million)
Table 103 Italy: Apheresis Market Size, By Product, 2014–2021 (USD Million)
Table 104 Italy: Market Size, By Device Type, 2014–2021 (USD Million)
Table 105 Italy: Apheresis Market Size, By Application, 2014–2021 (USD Million)
Table 106 Italy: Market Size, By Technology, 2014–2021 (USD Million)
Table 107 Spain: Apheresis Market Size, By Procedure, 2014–2021 (USD Million)
Table 108 Spain: Market Size, By Product, 2014–2021 (USD Million)
Table 109 Spain: Apheresis Market Size, By Device Type, 2014–2021 (USD Million)
Table 110 Spain: Market Size, By Application, 2014–2021 (USD Million)
Table 111 Spain: Apheresis Market Size, By Technology, 2014–2021 (USD Million)
Table 112 RoE: Market Size, By Procedure, 2014–2021 (USD Million)
Table 113 RoE: Apheresis Market Size, By Product, 2014–2021 (USD Million)
Table 114 RoE: Market Size, By Device Type, 2014–2021 (USD Million)
Table 115 RoE: Apheresis Market Size, By Application, 2014–2021 (USD Million)
Table 116 RoE: Market Size, By Technology, 2014–2021 (USD Million)
Table 117 APAC: Apheresis Market Size, By Country/Region, 2014–2021 (USD Million)
Table 118 APAC: Market Size, By Procedure, 2014–2021 (USD Million)
Table 119 APAC: Apheresis Market Size, By Product, 2014–2021 (USD Million)
Table 120 APAC: Market Size, By Device Type, 2014–2021 (USD Million)
Table 121 APAC: Apheresis Market Size, By Application, 2014–2021 (USD Million)
Table 122 APAC: Market Size, By Technology, 2014–2021 (USD Million)
Table 123 Japan: Apheresis Market Size, By Procedure, 2014–2021 (USD Million)
Table 124 Japan: Apheresis Market Size, By Product, 2014–2021 (USD Million)
Table 125 Japan: Market Size, By Device Type, 2014–2021 (USD Million)
Table 126 Japan: Apheresis Market Size, By Application, 2014–2021 (USD Million)
Table 127 Japan: Market Size, By Technology, 2014–2021 (USD Million)
Table 128 China: Apheresis Market Size, By Procedure, 2014–2021 (USD Million)
Table 129 China: Market Size, By Product, 2014–2021 (USD Million)
Table 130 China: Apheresis Market Size, By Device Type, 2014–2021 (USD Million)
Table 131 China: Market Size, By Application, 2014–2021 (USD Million)
Table 132 China: Apheresis Market Size, By Technology, 2014–2021 (USD Million)
Table 133 India: Apheresis Market Size, By Procedure, 2014–2021 (USD Million)
Table 134 India: Market Size, By Product, 2014-2021 (USD Million)
Table 135 India: Apheresis Market Size, By Device Type, 2014-2021 (USD Million)
Table 136 India: Market Size, By Application, 2014–2021 (USD Million)
Table 137 India: Market Size, By Technology, 2014–2021 (USD Million)
Table 138 RoAPAC: Apheresis Market Size, By Procedure, 2014–2021 (USD Million)
Table 139 RoAPAC: Apheresis Market Size, By Product, 2014–2021 (USD Million)
Table 140 RoAPAC: Apheresis Market Size, By Device Type, 2014–2021 (USD Million)
Table 141 RoAPAC: Apheresis Market Size, By Application, 2014–2021 (USD Million)
Table 142 RoAPAC: Apheresis Market Size, By Technology, 2014–2021 (USD Million)
Table 143 Latin America: Apheresis Market Size, By Country/Region, 2014–2021 (USD Million)
Table 144 Latin America: Apheresis Market Size, By Procedure, 2014–2021 (USD Million)
Table 145 Latin America: Apheresis Market Size, By Product, 2014–2021 (USD Million)
Table 146 Latin America: Apheresis Market Size, By Device Type, 2014–2021 (USD Million)
Table 147 Latin America: Apheresis Market Size, By Application, 2014–2021 (USD Million)
Table 148 Latin America: Apheresis Market Size, By Technology, 2014–2021 (USD Million)
Table 149 Number of Hemophilia Patients in Brazil: 2012–2015
Table 150 Brazil: Apheresis Market Size, By Procedure, 2014–2021 (USD Million)
Table 151 Brazil: Apheresis Market Size, By Product, 2014–2021 (USD Million)
Table 152 Brazil: Apheresis Market Size, By Device Type, 2014–2021 (USD Million)
Table 153 Brazil: Apheresis Market Size, By Application, 2014–2021 (USD Million)
Table 154 Brazil: Apheresis Market Size, By Technology, 2014–2021 (USD Million)
Table 155 Mexico: Apheresis Market Size, By Procedure, 2014–2021 (USD Million)
Table 156 Mexico: Apheresis Market Size, By Product, 2014–2021 (USD Million)
Table 157 Mexico: Apheresis Market Size, By Device Type, 2014–2021 (USD Million)
Table 158 Mexico: Apheresis Market Size, By Application, 2014–2021 (USD Million)
Table 159 Mexico: Apheresis Market Size, By Technology, 2014–2021 (USD Million)
Table 160 RoLA: Apheresis Market Size, By Procedure, 2014–2021 (USD Million)
Table 161 RoLA: Apheresis Market Size, By Product, 2014–2021 (USD Million)
Table 162 RoLA: Apheresis Market Size, By Device Type, 2014–2021 (USD Million)
Table 163 RoLA: Apheresis Market Size, By Application, 2014–2021 (USD Million)
Table 164 RoLA: Apheresis Market Size, By Technology, 2014–2021 (USD Million)
Table 165 Middle East and Africa: Apheresis Market Size, By Procedure, 2014–2021 (USD Million)
Table 166 Middle East and Africa: Apheresis Market Size, By Product, 2014–2021 (USD Million)
Table 167 Middle East and Africa: Apheresis Market Size, By Device Type, 2014–2021 (USD Million)
Table 168 Middle East and Africa: Apheresis Market Size, By Application, 2014–2021 (USD Million)
Table 169 Middle East and Africa: Apheresis Market Size, By Technology, 2014–2021 (USD Million)
Table 170 Agreements, Partnerships, and Collaborations, 2016
Table 171 Mergers and Acquisitions, 2012–2015
Table 172 Expansions, 2013–2015
Table 173 Product Launches, 2015
Table 174 Other Strategies, 2012–2015


List of Figures (47 Figures)

Figure 1 Apheresis Market Segmentation
Figure 2 Research Design
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Global Apheresis Market Size, By Procedure, 2016 vs 2021 (USD Million)
Figure 7 Global Therapeutic Apheresis Market Size, By Disease, 2016 vs 2021 (USD Million)
Figure 8 Global Therapeutic Apheresis Market Size, By Procedure, 2016 vs 2021 (USD Million)
Figure 9 Global Apheresis Market Size, By Product, 2016 vs 2021 (USD Million)
Figure 10 Global Apheresis Market Size, By Device Type, 2016 vs 2021 (USD Million)
Figure 11 Global Apheresis Market Size, By Application, 2016 vs 2021 (USD Million)
Figure 12 Global Apheresis Market Size, By Technology, 2016 vs 2021 (USD Million)
Figure 13 Global Apheresis Market Size, By Centrifugation Technology, 2016 vs 2021 (USD Million)
Figure 14 Geographical Snapshot of the Global Apheresis Market
Figure 15 Rising Prevalence of Diseases and Growing Number of Trauma and Injury Cases Driving the Growth of the Apheresis Market
Figure 16 Plasmapheresis Commanded the Largest Share in 2015
Figure 17 U.S. Accounted for Largest Share of the Apheresis Market in 2015
Figure 18 APAC to Grow at the Highest CAGR in the Forecast Period
Figure 19 Developing Markets to Register Highest Growth During the Forecast Period
Figure 20 Apheresis Market: Drivers, Restraints, Opportunities, & Challenges
Figure 21 Number of People With Chronic Conditions in the U.S. (Million Individuals)
Figure 22 Type of Plasma Processed Worldwide, 1996–2012 (Thousand Liters)
Figure 23 Source Plasma Collection in the U.S. & Europe, 2005–2013 (Thousand Liters)
Figure 24 Porter’s Five Forces Analysis: Apheresis Market
Figure 25 Therapeutic Apheresis, the Fastest-Growing Procedure Segment of the Apheresis Market
Figure 26 Disposables Product Segment to Register Highest Growth During the Forecast Period
Figure 27 Centrifugation Segment to Register the Highest CAGR During the Forecast Period
Figure 28 Other Applications to Witness Highest Growth in the Apheresis Market
Figure 29 Geographic Snapshot: Markets in Asia-Pacific are Growth Hotspots
Figure 30 Global Apheresis Market Share, By Region, 2015 vs 2021
Figure 31 North America: Apheresis Market Snapshot
Figure 32 Europe: Apheresis Market Snapshot
Figure 33 APAC: Apheresis Market Snapshot
Figure 34 Agreements, Collaborations, & Partnerships, the Most-Preferred Strategies Between 2012 and 2016
Figure 35 Global Apheresis Market Share Analysis, By Key Player, 2015
Figure 36 Battle for Market Share: Agreements, Collaborations, & Partnerships, the Key Strategies
Figure 37 Geographic Revenue Mix of Major Players
Figure 38 Cerus Corporation: Company Snapshot (2015)
Figure 39 Fresenius Medical Care: Company Snapshot (2015)
Figure 40 Fresenius Kabi: Company Snapshot (2015)
Figure 41 Asahi Kasei Corporation: Company Snapshot (2015)
Figure 42 Haemonetics Corporation: Company Snapshot (2015)
Figure 43 Terumo Corporation: Company Snapshot (2015)
Figure 44 B. Braun Melsungen AG: Company Snapshot (2015)
Figure 45 Kaneka Corporation: Company Snapshot (2015)
Figure 46 Kawasumi Laboratories, Inc.: Company Snapshot (2015)
Figure 47 Nikkiso Co., Ltd.: Company Snapshot (2015)

The global apheresis market is estimated to reach USD 2.06 Billion by 2021, at a CAGR of 7.7% during the forecast period. The increasing demand for blood components and growing concerns regarding blood safety across the globe, rising prevalence of various blood disorders, increasing number of surgical procedures and emergency care cases in hospitals around the world are driving market growth. Extending reach of apheresis in the untapped pediatric segment and growth in emerging markets due to increasing investments presents significant growth opportunities for players in this market. However, high costs of apheresis machines & procedures and scarcity of qualified donors are the major restraining factors for this market.

In this report, the market is segmented on the basis of procedure, product type, technology, application, and region. The research report discusses key market drivers, restraints, opportunities, and challenges in the global apheresis market and its submarkets. Based on product type, the market is segmented into devices and disposables. The disposables segment accounted for the largest share of the market in 2015; it is expected to grow at the highest CAGR during the forecast period. The increasing demand for disposables due to the rising number of therapeutic apheresis procedures being performed globally and the increasing trend towards apheresis blood collections are expected to drive the growth of this segment.

Based on technology, apheresis market is segmented into centrifugation and membrane separation technologies. The centrifugation technology segment accounted for the largest share of the global apheresis market in 2015. The large share of this segment can be attributed to the wide applications of centrifugation technology in the separation of plasma and cellular components of the blood.

In this report, the global apheresis market has been studied at the regional and country levels. In 2015, North America represented the largest regional market, followed by Europe. While North America will continue to dominate the market during the forecast period, the Asia-Pacific region is expected to register the highest growth. The growth of this regional segment is driven by the improving healthcare infrastructure, significant economic development in emerging markets, and rising focus of key market players in this region.

Apheresis Market

The major players in the global apheresis market are Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Therapeutic Markets on KnowledgeStore
Request Demo